This content is not available in your region

Botox-maker Allergan's revenue drops 3 percent

Botox-maker Allergan's revenue drops 3 percent
Text size Aa Aa

(Reuters) – Allergan Plc <AGN.N> reported a 3 percent drop in quarterly revenue on Tuesday, as its faces increasing competition for its Alzheimer’s treatment Namenda and other branded drugs.

The company posted net loss attributable to ordinary shareholders of $37.9 million (29.7 million pounds), or 11 cents per share, in the third quarter ended Sept. 30, compared with loss of $4.03 billion, or $12.07 per share, a year ago, which included a one-time charge.

Revenue fell 3 percent to $3.91 billion.

(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.